BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 30903310)

  • 21. Progression of Stargardt Disease as Determined by Fundus Autofluorescence in the Retrospective Progression of Stargardt Disease Study (ProgStar Report No. 9).
    Strauss RW; Muñoz B; Ho A; Jha A; Michaelides M; Cideciyan AV; Audo I; Birch DG; Hariri AH; Nittala MG; Sadda S; West S; Scholl HPN;
    JAMA Ophthalmol; 2017 Nov; 135(11):1232-1241. PubMed ID: 29049437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular abnormalities in patients with Stargardt disease assessed with optical coherence tomography angiography.
    Battaglia Parodi M; Cicinelli MV; Rabiolo A; Pierro L; Bolognesi G; Bandello F
    Br J Ophthalmol; 2017 Jun; 101(6):780-785. PubMed ID: 27628426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A longitudinal study of Stargardt disease: quantitative assessment of fundus autofluorescence, progression, and genotype correlations.
    Fujinami K; Lois N; Mukherjee R; McBain VA; Tsunoda K; Tsubota K; Stone EM; Fitzke FW; Bunce C; Moore AT; Webster AR; Michaelides M
    Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8181-90. PubMed ID: 24265018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential Disease Progression in Atrophic Age-Related Macular Degeneration and Late-Onset Stargardt Disease.
    Lindner M; Lambertus S; Mauschitz MM; Bax NM; Kersten E; Lüning A; Nadal J; Schmitz-Valckenberg S; Schmid M; Holz FG; Hoyng CB; Fleckenstein M;
    Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):1001-1007. PubMed ID: 28288486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ASSOCIATION BETWEEN GENOTYPE AND DISEASE PROGRESSION IN ITALIAN STARGARDT PATIENTS: A Retrospective Natural History Study.
    Di Iorio V; Orrico A; Esposito G; Melillo P; Rossi S; Sbordone S; Auricchio A; Testa F; Simonelli F
    Retina; 2019 Jul; 39(7):1399-1409. PubMed ID: 29642238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study of Late-Onset Stargardt Type 1 Disease: Characteristics, Genetics, and Progression.
    Li CHZ; Pas JAAH; Corradi Z; Hitti-Malin RJ; Hoogstede A; Runhart EH; Dhooge PPA; Collin RWJ; Cremers FPM; Hoyng CB
    Ophthalmology; 2024 Jan; 131(1):87-97. PubMed ID: 37598860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies: Design and Baseline Characteristics: ProgStar Report No. 1.
    Strauss RW; Ho A; Muñoz B; Cideciyan AV; Sahel JA; Sunness JS; Birch DG; Bernstein PS; Michaelides M; Traboulsi EI; Zrenner E; Sadda S; Ervin AM; West S; Scholl HP;
    Ophthalmology; 2016 Apr; 123(4):817-28. PubMed ID: 26786511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical, Genotypic, and Imaging Characterization of the Spectrum of ABCA4 Retinopathies.
    Romano F; Lamanna F; Boon CJF; Siligato A; Kalra G; Agarwal A; Medori C; Bertelli M; Pellegrini M; Invernizzi A; Staurenghi G; Salvetti AP
    Ophthalmol Retina; 2024 May; 8(5):509-519. PubMed ID: 37924945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progression of Late-Onset Stargardt Disease.
    Lambertus S; Lindner M; Bax NM; Mauschitz MM; Nadal J; Schmid M; Schmitz-Valckenberg S; den Hollander AI; Weber BH; Holz FG; van der Wilt GJ; Fleckenstein M; Hoyng CB;
    Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5186-5191. PubMed ID: 27699414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of fundus autofluorescence and retinal structure in patients with Stargardt disease.
    Gomes NL; Greenstein VC; Carlson JN; Tsang SH; Smith RT; Carr RE; Hood DC; Chang S
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3953-9. PubMed ID: 19324865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abnormality in the external limiting membrane in early Stargardt disease.
    Burke TR; Yzer S; Zernant J; Smith RT; Tsang SH; Allikmets R
    Ophthalmic Genet; 2013; 34(1-2):75-7. PubMed ID: 22871184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Photoreceptor Progenitor mRNA Analysis Reveals Exon Skipping Resulting from the ABCA4 c.5461-10T→C Mutation in Stargardt Disease.
    Sangermano R; Bax NM; Bauwens M; van den Born LI; De Baere E; Garanto A; Collin RW; Goercharn-Ramlal AS; den Engelsman-van Dijk AH; Rohrschneider K; Hoyng CB; Cremers FP; Albert S
    Ophthalmology; 2016 Jun; 123(6):1375-85. PubMed ID: 26976702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macular Sensitivity Measured With Microperimetry in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 7.
    Schönbach EM; Wolfson Y; Strauss RW; Ibrahim MA; Kong X; Muñoz B; Birch DG; Cideciyan AV; Hahn GA; Nittala M; Sunness JS; Sadda SR; West SK; Scholl HPN;
    JAMA Ophthalmol; 2017 Jul; 135(7):696-703. PubMed ID: 28542693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. En face OCT in Stargardt disease.
    Sodi A; Mucciolo DP; Cipollini F; Murro V; Caporossi O; Virgili G; Rizzo S
    Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1669-79. PubMed ID: 26743751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insights into autofluorescence patterns in Stargardt macular dystrophy using ultra-wide-field imaging.
    Kumar V
    Graefes Arch Clin Exp Ophthalmol; 2017 Oct; 255(10):1917-1922. PubMed ID: 28689222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HYPERREFLECTIVE DEPOSITION IN THE BACKGROUND OF ADVANCED STARGARDT DISEASE.
    Ciccone L; Lee W; Zernant J; Tanaka K; Schuerch K; Tsang SH; Allikmets R
    Retina; 2018 Nov; 38(11):2214-2219. PubMed ID: 29028687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative Fundus Autofluorescence in ABCA4-Related Retinopathy -Functional Relevance and Genotype-Phenotype Correlation.
    Müller PL; Gliem M; McGuinnes M; Birtel J; Holz FG; Charbel Issa P
    Am J Ophthalmol; 2021 Feb; 222():340-350. PubMed ID: 32891696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Highly Variable Disease Courses in Siblings with Stargardt Disease.
    Valkenburg D; Runhart EH; Bax NM; Liefers B; Lambertus SL; Sánchez CI; Cremers FPM; Hoyng CB
    Ophthalmology; 2019 Dec; 126(12):1712-1721. PubMed ID: 31522899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of Atrophic Lesions in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 5.
    Strauss RW; Muñoz B; Ho A; Jha A; Michaelides M; Mohand-Said S; Cideciyan AV; Birch D; Hariri AH; Nittala MG; Sadda S; Scholl HPN;
    JAMA Ophthalmol; 2017 Jul; 135(7):687-695. PubMed ID: 28542697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Full-field ERG as a predictor of the natural course of
    Schroeder M; Kjellström U
    Mol Vis; 2018; 24():1-16. PubMed ID: 29386879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.